Exuma Biotech Competitors and Similar CompaniesClear all

Exuma Biotech's competitors and similar companies include Symphogen, Epizyme and BioLineRx.

	Exuma Biotech EXUMA Biotechnology (formerly known as F1 Oncology) is a clinical-stage biotechnology company.	Symphogen Symphogen is a biotech company focused on oncology and immuno-oncology.	Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.	BioLineRx BioLineRx is a biopharmaceutical company focused on oncology.
Founding Date	Founding Date 2015	Founding Date 2000	Founding Date 2007	Founding Date 2003
Type	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations West Palm Beach, US HQ George Town, KY Sacramento, US	Locations Ballerup, DK HQ Somerville, US	Locations Cambridge, US HQ	Locations Modi'in-Maccabim-Re'ut, IL HQ
Employees	Employees 257% decrease	Employees 196	Employees 20364% increase	Employees 2414% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 250.8 m	Valuation ($) 38.5 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $37.4m (FY, 2021)	Revenue (est.) $1.2m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $10.5m (FY, 2021)	Cost of goods $230k (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ($251.1m) (FY, 2021)	Net income ($2m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 29m	Total funding raised $ 387.2m	Total funding raised $ 51.5m	Total funding raised $ 100.9m